Customize Consent Preferences

We use cookies to help you navigate efficiently and perform certain functions. You will find detailed information about all cookies under each consent category below.

The cookies that are categorized as "Necessary" are stored on your browser as they are essential for enabling the basic functionalities of the site. ... 

Always Active

Necessary cookies are required to enable the basic features of this site, such as providing secure log-in or adjusting your consent preferences. These cookies do not store any personally identifiable data.

Functional cookies help perform certain functionalities like sharing the content of the website on social media platforms, collecting feedback, and other third-party features.

Analytical cookies are used to understand how visitors interact with the website. These cookies help provide information on metrics such as the number of visitors, bounce rate, traffic source, etc.

Performance cookies are used to understand and analyze the key performance indexes of the website which helps in delivering a better user experience for the visitors.

No cookies to display.

Advertisement cookies are used to provide visitors with customized advertisements based on the pages you visited previously and to analyze the effectiveness of the ad campaigns.

    Get Diamond plan for FREE

    logo

    Akumin Inc. (AKU)

    Price:

    0.29 USD

    ( - -0.06 USD)

    Your position:

    0 USD

    ACTION PANEL
    CREATE A NOTE
    ABOUT
    Symbol
    AKU
    Name
    Akumin Inc.
    Industry
    Medical - Diagnostics & Research
    Sector
    Healthcare
    Price
    0.289
    Market Cap
    26.271M
    Enterprise value
    1.484B
    Currency
    USD
    Ceo
    Riadh Zine-El-Abidine
    Full Time Employees
    1737
    Website
    Ipo Date
    2020-09-03
    City
    Plantation
    Address
    8300 West Sunrise Boulevard

    Check the

    KEY TAKEAWAYS

    ASK OUR AI ABOUT THE COMPANY (REGISTER FOR EARLY ACCESS)
    Descriptive alt text

    (REGISTER FOR EARLY ACCESS) CHOOSE A PROMPT ABOVE TO ASK OUR AI ABOUT THE SPECIFIC INFORMATION

    SIMILAR COMPANIES STI SCORE

    Similar STI Score

    Syneos Health, Inc.

    VALUE SCORE:

    0

    Symbol
    SYNH
    Market Cap
    4.458B
    Industry
    Medical - Diagnostics & Research
    Sector
    Healthcare

    2nd position

    GRAIL, Inc.

    VALUE SCORE:

    9

    Symbol
    GRAL
    Market Cap
    3.173B
    Industry
    Medical - Diagnostics & Research
    Sector
    Healthcare

    The best

    Medpace Holdings, Inc.

    VALUE SCORE:

    9

    Symbol
    MEDP
    Market Cap
    15.712B
    Industry
    Medical - Diagnostics & Research
    Sector
    Healthcare
    FUNDAMENTALS
    P/E
    -0.170
    P/S
    0.035
    P/B
    -0.536
    Debt/Equity
    -30.697
    EV/FCF
    70.200
    Price to operating cash flow
    -1.000
    Price to free cash flow
    -1.000
    EV/sales
    1.930
    Earnings yield
    -5.869
    Debt/assets
    0.838
    FUNDAMENTALS
    Net debt/ebidta
    10.154
    Interest coverage
    0.353
    Research And Developement To Revenue
    0
    Intangile to total assets
    0.658
    Capex to operating cash flow
    0.685
    Capex to revenue
    0.060
    Capex to depreciation
    0.456
    Return on tangible assets
    -0.251
    Debt to market cap
    56.321
    Piotroski Score
    4.000
    FUNDAMENTALS
    PEG
    -0.002
    P/CF
    0.395
    P/FCF
    1.275
    RoA %
    -8.588
    RoIC %
    2.687
    Gross Profit Margin %
    18.843
    Quick Ratio
    1.092
    Current Ratio
    1.139
    Net Profit Margin %
    -20.222
    Net-Net
    -16.485
    FUNDAMENTALS PER SHARE
    FCF per share
    0.230
    Revenue per share
    8.380
    Net income per share
    -1.694
    Operating cash flow per share
    0.731
    Free cash flow per share
    0.230
    Cash per share
    0.664
    Book value per share
    1.579
    Tangible book value per share
    -11.401
    Shareholders equity per share
    -0.539
    Interest debt per share
    17.859
    TECHNICAL
    52 weeks high
    1.900
    52 weeks low
    0.118
    Current trading session High
    0.350
    Current trading session Low
    0.280
    DIVIDEND
    Dividend yield
    0.00%
    Payout ratio
    0.00%
    Years of div. Increase
    0
    Years of div.
    0
    Q-shift
    Dividend per share
    0
    SIMILAR COMPANIES
    logo

    Country
    GB
    Sector
    Healthcare
    Industry
    Medical - Diagnostics & Research
    Dividend yield
    0%
    Payout Ratio
    0%
    P/E
    -12.459
    logo

    Country
    US
    Sector
    Healthcare
    Industry
    Medical - Diagnostics & Research
    Dividend yield
    0%
    Payout Ratio
    0%
    P/E
    -0.276

    No data to display

    logo

    Country
    DE
    Sector
    Healthcare
    Industry
    Medical - Diagnostics & Research
    Dividend yield
    0%
    Payout Ratio
    0%
    P/E
    -0.219
    logo

    Country
    US
    Sector
    Healthcare
    Industry
    Medical - Diagnostics & Research
    Dividend yield
    0%
    Payout Ratio
    0%
    P/E
    -0.000

    No data to display

    logo

    Country
    GB
    Sector
    Healthcare
    Industry
    Medical - Diagnostics & Research
    Dividend yield
    0%
    Payout Ratio
    0%
    P/E
    -0.010

    No data to display

    logo

    Country
    US
    Sector
    Healthcare
    Industry
    Medical - Diagnostics & Research
    Dividend yield
    0%
    Payout Ratio
    0%
    P/E
    -0.071
    logo

    Country
    BE
    Sector
    Healthcare
    Industry
    Medical - Diagnostics & Research
    Dividend yield
    0%
    Payout Ratio
    0%
    P/E
    -4.910

    No data to display

    logo

    Country
    US
    Sector
    Healthcare
    Industry
    Medical - Diagnostics & Research
    Dividend yield
    0%
    Payout Ratio
    0%
    P/E
    -0.001

    No data to display

    logo

    Country
    US
    Sector
    Healthcare
    Industry
    Medical - Diagnostics & Research
    Dividend yield
    0%
    Payout Ratio
    77.76204%
    P/E
    11.598

    No data to display

    logo

    Country
    GB
    Sector
    Healthcare
    Industry
    Medical - Diagnostics & Research
    Dividend yield
    0%
    Payout Ratio
    0%
    P/E
    -0.097
    DESCRIPTION

    Akumin Inc. provides outpatient diagnostic imaging services in the United States. It operates in two segments, Radiology and Oncology. The company offers various medical imaging services, including magnetic resonance imaging, computed tomography, positron emission tomography, nuclear medicine, mammography, ultrasound, digital radiography, fluoroscopy, and other diagnostic or interventional radiology procedures through a network of approximately 200 owned and/or operated imaging locations. It provides outpatient radiology, and oncology services and solutions to approximately 1,000 hospitals and health systems across 46 states. Akumin Inc. was founded in 2015 and is headquartered in Plantation, Florida.

    NEWS
    https://images.financialmodelingprep.com/news/why-is-akumin-aku-stock-up-51-today-20231023.jpg
    Why Is Akumin (AKU) Stock Up 51% Today?

    investorplace.com

    2023-10-23 08:07:43

    Akumin (NASDAQ: AKU ) stock is climbing higher on Monday after the outpatient diagnostic imaging services company agreed to be taken private. According to a press release from Akumin, the company has reached a go-private agreement with alternative investment firm Stonepeak.

    https://images.financialmodelingprep.com/news/akumin-inc-reaches-agreement-with-stonepeak-to-become-a-20231020.jpg
    Akumin Inc. Reaches Agreement with Stonepeak to Become a Private Company

    prnewswire.com

    2023-10-20 17:00:00

    Financial restructuring to fortify balance sheet and provide liquidity runway for next stage of growth Approvals received from key stakeholders across capital structure; transaction will  be implemented through prepackaged court-supervised process; Expected to obtain court approval within the next 45 days Business will continue to operate as usual without interruption; trade creditors, employees, and other partners expected to continue to be paid in ordinary course PLANTATION, Fla. , Oct. 20, 2023 /PRNewswire/ - Akumin Inc. ("Akumin" or the "Company") (NASDAQ: AKU) (TSX: AKU) announced today that it has reached an agreement with Stonepeak, a leading alternative investment firm specializing in infrastructure and real assets, and the Company's stakeholders on the terms of a financial restructuring that will substantially improve the Company's balance sheet and provide ample liquidity to position Akumin for future success.

    https://images.financialmodelingprep.com/news/akumin-inc-aku-q2-2023-earnings-call-transcript-20230812.jpg
    Akumin Inc. (AKU) Q2 2023 Earnings Call Transcript

    seekingalpha.com

    2023-08-12 13:08:10

    Akumin Inc. (NASDAQ:AKU ) Q2 2023 Earnings Conference Call August 10, 2023 8:30 AM ET Company Participants Riadh Zine - Chairman & CEO David Kretschmer - CFO Conference Call Participants Noel Atkinson - Clarus Securities Rishi Parekh - JPMorgan Operator Good morning. My name is Lara, and I will be your conference operator today.

    https://images.financialmodelingprep.com/news/akumin-announces-change-of-auditor-20230809.jpg
    Akumin Announces Change of Auditor

    prnewswire.com

    2023-08-09 17:31:00

    PLANTATION, Fla. , Aug. 9, 2023 /PRNewswire/ - Akumin Inc. ("Akumin" or the "Company") (NASDAQ: AKU) (TSX: AKU) announced today that it has changed its auditor from Ernst & Young LLP ("EY") to Deloitte & Touche LLP ("Deloitte").

    https://images.financialmodelingprep.com/news/akumin-announces-second-quarter-2023-results-revised-fy23-financial-20230809.jpg
    Akumin Announces Second Quarter 2023 Results, Revised FY23 Financial Outlook and Establishment of Special Committee

    prnewswire.com

    2023-08-09 17:23:00

    PLANTATION, Fla. , Aug. 9, 2023 /PRNewswire/ - Akumin Inc. (NASDAQ: AKU) (TSX: AKU) ("Akumin" or the "Company"), a national partner of choice for U.S. hospitals, health systems and physician groups, with comprehensive solutions addressing outsourced radiology and oncology service-line needs, announced today its financial results for the quarter ended June 30, 2023.

    https://images.financialmodelingprep.com/news/akumin-to-host-second-quarter-2023-financial-results-call-20230808.jpg
    Akumin to Host Second Quarter 2023 Financial Results Call on August 10, 2023

    prnewswire.com

    2023-08-08 17:23:00

    PLANTATION, Fla., Aug. 8, 2023 /PRNewswire/ - Akumin Inc. (NASDAQ/TSX: AKU) ("Akumin" or the "Company") will host a conference call at 8:30 a.m. Eastern Time, Thursday, August 10, 2023, to discuss its second quarter 2023 financial results. The financial results are expected to be available on Wednesday, August 9, 2023.

    https://images.financialmodelingprep.com/news/why-is-akumin-aku-stock-up-31-today-20230706.png
    Why Is Akumin (AKU) Stock Up 31% Today?

    investorplace.com

    2023-07-06 08:25:11

    Akumin (NASDAQ: AKU ) stock is taking off on Thursday alongside heavy trading of the company's shares this morning. There are no new press releases or filings with the Securities and Exchange Commission (SEC) that explain why shares of AKU stock are on the rise this morning.

    https://images.financialmodelingprep.com/news/akumin-inc-aku-q1-2023-earnings-call-transcript-20230514.jpg
    Akumin Inc. (AKU) Q1 2023 Earnings Call Transcript

    seekingalpha.com

    2023-05-14 04:13:15

    Akumin Inc. (NASDAQ:AKU ) Q1 2023 Earnings Conference Call May 11, 2023 8:30 AM ET Company Participants Riadh Zine - Chairman & CEO David Kretschmer - CFO Conference Call Participants Noel Atkinson - Clarus Securities Inc. Andre Bodo - National Bank of Canada Rishi Parekh - JPMorgan Operator Good morning. My name is Laura, and I will be your conference operator today.

    https://images.financialmodelingprep.com/news/akumin-to-host-yearend-2022-financial-results-call-on-20230310.jpg
    Akumin to Host Year-end 2022 Financial Results Call on March 17, 2023

    prnewswire.com

    2023-03-10 17:30:00

    PLANTATION, Fla. , March 10, 2023 /PRNewswire/ - Akumin Inc. (NASDAQ: AKU) (TSX: AKU) ("Akumin" or the "Company") will host a conference call at 8:30 a.m.

    https://images.financialmodelingprep.com/news/akumin-inc-aku-q3-2022-earnings-call-transcript-20221112.jpg
    Akumin Inc. (AKU) Q3 2022 Earnings Call Transcript

    seekingalpha.com

    2022-11-12 12:58:06

    Akumin Inc. (NASDAQ:AKU ) Q3 2022 Earnings Conference Call November 10, 2022 8:30 AM ET Company Participants Riadh Zine - Chairman and Chief Executive Officer David Kretschmer - Interim Chief Financial Officer Conference Call Participants Noel Atkinson - Clarus Securities Operator Good morning. My name is Simon and I will be your conference operator today.

    https://images.financialmodelingprep.com/news/akumin-incs-aku-ceo-riadh-zine-on-q2-2022-20220810.jpg
    Akumin Inc.'s (AKU) CEO Riadh Zine on Q2 2022 Results - Earnings Call Transcript

    seekingalpha.com

    2022-08-10 13:11:28

    Akumin Inc. (NASDAQ:AKU ) Q2 2022 Earnings Conference Call August 10, 2022 8:30 AM ET Company Participants Matt Cameron – Chief Legal Officer and Corporate Secretary Riadh Zine – Chairman and Chief Executive Officer Bill Larkin – Chief Financial Officer Conference Call Participants Noel Atkinson – Clarus Securities Operator Good morning. My name is Darren and I will be your conference operator today.

    https://images.financialmodelingprep.com/news/akumin-to-host-second-quarter-2022-financial-results-call-20220804.jpg
    Akumin to Host Second Quarter 2022 Financial Results Call on August 10, 2022

    prnewswire.com

    2022-08-04 20:35:00

    PLANTATION, Fla. , Aug. 4, 2022 /PRNewswire/ - Akumin Inc. (NASDAQ: AKU) (TSX: AKU) ("Akumin" or the "Company") will host a conference call at 8:30 a.m.

    https://images.financialmodelingprep.com/news/akumin-inc-aku-ceo-riadh-zine-on-q1-2022-20220513.jpg
    Akumin, Inc. (AKU) CEO Riadh Zine on Q1 2022 Results - Earnings Call Transcript

    seekingalpha.com

    2022-05-13 16:27:14

    Akumin, Inc. (NASDAQ:AKU ) Q1 2022 Earnings Conference Call May 11, 2022 8:30 AM ET Company Participants Matthew Cameron - Chief Legal Officer & Corporate Secretary Riadh Zine - Chairman & Chief Executive Officer Bill Larkin - Chief Financial Officer Conference Call Participants Noel Atkinson - Clarus Securities Tania Armstrong-Whitworth - CGF Endri Leno - National Bank Rishi Parekh - Barclays Operator Good morning. My name is Sergey, and I will be your conference operator today.

    https://images.financialmodelingprep.com/news/new-strong-sell-stocks-for-april-6th-20220406.jpeg
    New Strong Sell Stocks for April 6th

    zacks.com

    2022-04-06 09:47:22

    AKU, AOMR, and CTRA have been added to the Zacks Rank #5 (Strong Sell) List on April 6, 2022.

    https://images.financialmodelingprep.com/news/new-strong-sell-stocks-for-april-4th-20220404.jpeg
    New Strong Sell Stocks for April 4th

    zacks.com

    2022-04-04 09:02:05

    AKU, ANIK, and AY have been added to the Zacks Rank #5 (Strong Sell) List on April 4, 2022.

    https://images.financialmodelingprep.com/news/new-strong-sell-stocks-for-march-21st-20220321.jpeg
    New Strong Sell Stocks for March 21st

    zacks.com

    2022-03-21 11:17:38

    ARAY, AKU, and ANIK have been added to the Zacks Rank #5 (Strong Sell) List on March 21, 2022